Nystatin Unit Dose Recommendations
For oral candidiasis (oropharyngeal thrush), prescribe nystatin suspension 100,000 U/mL at 4-6 mL four times daily, or nystatin pastilles 200,000 U each, 1-2 pastilles four times daily for 7-14 days. 1
Oral Candidiasis Dosing
The 2016 IDSA guidelines provide clear dosing for mild oropharyngeal candidiasis:
- Nystatin suspension: 100,000 U/mL concentration, dose 4-6 mL (400,000-600,000 units) four times daily
- Nystatin pastilles: 200,000 U each, take 1-2 pastilles (200,000-400,000 units) four times daily
- Duration: 7-14 days for both formulations 1
This represents a strong recommendation with moderate-quality evidence specifically for mild disease. The FDA-approved oral suspension contains 100,000 units per mL 2, and unit dose cups deliver 500,000 units per 5 mL 2.
Important Clinical Considerations
Nystatin is an alternative agent, not first-line. The IDSA guidelines recommend clotrimazole troches (10 mg 5 times daily) or miconazole buccal tablets as preferred options for mild disease, with stronger evidence (high-quality vs. moderate-quality for nystatin) 1. For moderate-to-severe disease, oral fluconazole 100-200 mg daily is the recommended first-line therapy.
Formulation matters for efficacy. Research suggests that nystatin pastilles alone or in combination with suspension are more effective than suspension alone 3. Higher doses (400,000 IU pastilles) achieve better mycological cure rates than lower doses (200,000 IU), and extending treatment to 4 weeks may improve outcomes compared to 2 weeks 3.
Topical (Cutaneous) Candidiasis Dosing
For cutaneous candidiasis, prescribe nystatin topical powder 100,000 USP units per gram, applied to affected area 2-3 times daily. 4
The FDA-approved topical powder formulation contains 100,000 units per gram and should be applied 2-3 times daily to affected skin areas 4.
Vaginal Candidiasis Dosing
For vaginal candidiasis, nystatin is NOT recommended as monotherapy. The IDSA guidelines state that topical antifungal agents are appropriate for uncomplicated vulvovaginal candidiasis but do not specify nystatin dosing, as azole antifungals are preferred 1.
When nystatin is used vaginally (typically in combination products), research supports:
- Combination formulation: Nystatin 100,000-200,000 IU per vaginal suppository once daily 5, 6
- Duration: 5-10 days depending on dose 6
However, older comparative data shows nystatin 100,000 units daily for 14 days had significantly higher relapse rates compared to azole antifungals 7, making it a suboptimal choice.
Critical Pitfalls to Avoid
Sugar content in suspensions: Many commercial nystatin oral suspensions contain 50% sucrose 2, which can promote dental caries and is problematic for diabetic patients. Consider sugar-free formulations when available 8.
Alcohol content: Some formulations contain up to 1% alcohol 2, which may be contraindicated in certain patients (children, recovering alcoholics, patients on disulfiram/metronidazole).
Poor taste compliance: Nystatin has notoriously poor taste, leading to adherence issues, particularly in children 3, 8. This is a major limitation compared to azole alternatives.
Swish-and-swallow technique: For oral candidiasis, patients must be instructed to swish the suspension throughout the mouth before swallowing to ensure adequate mucosal contact. Pastilles should be allowed to dissolve slowly in the mouth, not chewed or swallowed whole.
Denture management: For denture-related candidiasis, concurrent denture disinfection is mandatory alongside antifungal therapy 1.